Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1988 Mar;43(3):163–169. doi: 10.1136/thx.43.3.163

Pulmonary function after bone marrow transplantation for chronic myeloid leukaemia.

T G Sutedja 1, J F Apperley 1, J M Hughes 1, V R Aber 1, H G Kennedy 1, P Nunn 1, L Jones 1, L Hopper 1, J M Goldman 1
PMCID: PMC461154  PMID: 3043753

Abstract

Pulmonary function was measured before and at intervals after treatment in 44 patients who received a bone marrow transplant for chronic myeloid leukaemia in the chronic phase. All patients were treated with cytotoxic drugs, total body irradiation, and post-graft immunosuppression. Thirty four patients surviving for 12 months were followed at three monthly intervals and 16 patients for 24 months. Fifteen patients received unmanipulated donor marrow cells and 29 patients received donor marrow cells depleted of lymphocytes ex vivo with the monoclonal antibody Campath-1. The 21 patients treated early in this study received 10 Gy of total body irradiation whereas the 23 patients treated more recently, who were all T lymphocyte depleted, received 12 Gy. Pretransplant lung function for the group was normal and was similar in survivors (n = 34) and nonsurvivors (n = 10), and in smokers (n = 8) and non-smokers (n = 36). (Carbon monoxide transfer factor--TLCO) was under 75% of predicted normal in nine patients before transplantation. TLCO, carbon monoxide transfer coefficient (KCO), FEV1, and vital capacity (VC) values were lower 6 and 12 months after bone marrow transplant than initially. The greatest decline was in TLCO, from an initial value of 89% to 66% at 6 and 70% at 12 months. The 16 longer term survivors showed significant recovery of function between 6 and 24 months after bone marrow transplant for TLCO, KCO, and VC, the increase ranging from 6.3% to 7.3% predicted. Airflow obstruction (FEV1/VC ratio less than 70%) developed in one patient. The major factors associated with deterioration in pulmonary function at 6 and 12 months after transplantation in the 34 survivors (stepwise multiple regression analysis) were (a) transplantation with T cell depleted donor marrow (p less than 0.005) and higher total body irradiation dose (p less than 0.02) with a fall in KCO and an increase in the FEV1/VC ratio; (b) chronic graft versus host disease with a fall in VC (p less than 0.01); and less fall in KCO (p less than 0.01); and (c) acute graft versus host disease with a fall in FEV1 (p less than 0.01). It is considered that most patients who survive the short term risks of bone marrow transplant have only minor long term impairment of pulmonary function.

Full text

PDF
163

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apperley J. F., Jones L., Hale G., Waldmann H., Hows J., Rombos Y., Tsatalas C., Marcus R. E., Goolden A. W., Gordon-Smith E. C. Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse. Bone Marrow Transplant. 1986 May;1(1):53–66. [PubMed] [Google Scholar]
  2. Beschorner W. E., Saral R., Hutchins G. M., Tutschka P. J., Santos G. W. Lymphocytic bronchitis associated with graft-versus-host disease in recipients of bone-marrow transplants. N Engl J Med. 1978 Nov 9;299(19):1030–1036. doi: 10.1056/NEJM197811092991902. [DOI] [PubMed] [Google Scholar]
  3. Bortin M. M., Kay H. E., Gale R. P., Rimm A. A. Factors associated with interstitial pneumonitis after bone-marrow transplantation for acute leukaemia. Lancet. 1982 Feb 20;1(8269):437–439. doi: 10.1016/s0140-6736(82)91633-6. [DOI] [PubMed] [Google Scholar]
  4. Bradley J., Bye C., Hayden S. P., Hughes D. T. Normal values of transfer factor and transfer coefficients in healthy males and females. Respiration. 1979;38(4):221–226. doi: 10.1159/000194084. [DOI] [PubMed] [Google Scholar]
  5. Clift R. A., Buckner C. D., Thomas E. D., Doney K., Fefer A., Neiman P. E., Singer J., Sanders J., Stewart P., Sullivan K. M. Treatment of chronic granulocytic leukaemia in chronic phase by allogeneic marrow transplantation. Lancet. 1982 Sep 18;2(8299):621–623. doi: 10.1016/s0140-6736(82)92735-0. [DOI] [PubMed] [Google Scholar]
  6. Cooper J. A., Jr, White D. A., Matthay R. A. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. Am Rev Respir Dis. 1986 Feb;133(2):321–340. doi: 10.1164/arrd.1986.133.2.321. [DOI] [PubMed] [Google Scholar]
  7. Cotes J. E., Dabbs J. M., Elwood P. C., Hall A. M., McDonald A., Saunders M. J. Iron-deficiency anaemia: its effect on transfer factor for the lung (diffusiong capacity) and ventilation and cardiac frequency during sub-maximal exercise. Clin Sci. 1972 Mar;42(3):325–335. doi: 10.1042/cs0420325. [DOI] [PubMed] [Google Scholar]
  8. Depledge M. H., Barrett A., Powles R. L. Lung function after bone marrow grafting. Int J Radiat Oncol Biol Phys. 1983 Feb;9(2):145–151. doi: 10.1016/0360-3016(83)90091-3. [DOI] [PubMed] [Google Scholar]
  9. Gibson G. J., Pride N. B. Pulmonary mechanics in fibrosing alveolitis: the effects of lung shrinkage. Am Rev Respir Dis. 1977 Oct;116(4):637–647. doi: 10.1164/arrd.1977.116.4.637. [DOI] [PubMed] [Google Scholar]
  10. Link H., Reinhard U., Blaurock M., Ostendorf P. Lung function changes after allogenic bone marrow transplantation. Thorax. 1986 Jul;41(7):508–512. doi: 10.1136/thx.41.7.508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Powles R. L., Clink H. M., Spence D., Morgenstern G., Watson J. G., Selby P. J., Woods M., Barrett A., Jameson B., Sloane J. Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation. Lancet. 1980 Feb 16;1(8164):327–329. doi: 10.1016/s0140-6736(80)90881-8. [DOI] [PubMed] [Google Scholar]
  12. Prentice H. G. A review of the current status and techniques of allogeneic bone marrow transplantation for treatment of leukaemia. J Clin Pathol. 1983 Nov;36(11):1207–1214. doi: 10.1136/jcp.36.11.1207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ralph D. D., Springmeyer S. C., Sullivan K. M., Hackman R. C., Storb R., Thomas E. D. Rapidly progressive air-flow obstruction in marrow transplant recipients. Possible association between obliterative bronchiolitis and chronic graft-versus-host disease. Am Rev Respir Dis. 1984 Apr;129(4):641–644. [PubMed] [Google Scholar]
  14. Roca J., Grañeña A., Rodriguez-Roisin R., Alvarez P., Agusti-Vidal A., Rozman C. Fatal airway disease in an adult with chronic graft-versus-host disease. Thorax. 1982 Jan;37(1):77–78. doi: 10.1136/thx.37.1.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sloane J. P., Depledge M. H., Powles R. L., Morgenstern G. R., Trickey B. S., Dady P. J. Histopathology of the lung after bone marrow transplantation. J Clin Pathol. 1983 May;36(5):546–554. doi: 10.1136/jcp.36.5.546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sørensen P. G., Ernst P., Panduro J., Møller J. Reduced lung function in leukaemia patients undergoing bone marrow transplantation. Scand J Haematol. 1984 Mar;32(3):253–257. doi: 10.1111/j.1600-0609.1984.tb01689.x. [DOI] [PubMed] [Google Scholar]
  17. Thomas E., Storb R., Clift R. A., Fefer A., Johnson F. L., Neiman P. E., Lerner K. G., Glucksberg H., Buckner C. D. Bone-marrow transplantation (first of two parts). N Engl J Med. 1975 Apr 17;292(16):832–843. doi: 10.1056/NEJM197504172921605. [DOI] [PubMed] [Google Scholar]
  18. Wyatt S. E., Nunn P., Hows J. M., Yin J., Hayes M. C., Catovsky D., Gordon-Smith E. C., Hughes J. M., Goldman J. M., Galton D. Airways obstruction associated with graft versus host disease after bone marrow transplantation. Thorax. 1984 Dec;39(12):887–894. doi: 10.1136/thx.39.12.887. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES